StonvexLoading…
StonvexStonvexStonvexCore line items from STRR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $140.06M | $161.34M | $200.92M | $169.21M |
Operating Income | $-3.81M | $1.38M | $9.34M | $4.39M |
Net Income | $-4.77M | $2.20M | $7.13M | $3.23M |
EPS (Diluted) | $-1.59 | $0.70 | $2.27 | $1.07 |
Total Assets | $52.58M | $60.96M | $67.94M | $61.24M |
Total Liabilities | $12.15M | $12.40M | $22.15M | $21.93M |
Cash & Equivalents | $17.01M | $22.61M | $27.12M | $21.71M |
Free Cash Flow OCF − CapEx | $-2.81M | $216.00K | $8.95M | $2.22M |
Shares Outstanding | 2.75M | 2.81M | 2.79M | 2.71M |